BEIJING, Nov. 8, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced the initiation of exploring the integration of Reinforcement Learning (RL) into the federated learning framework. RL, as a significant branch of machine learning, has become a crucial tool for optimizing the federated learning process due to its decision-making capabilities in complex environments.

Reinforcement Learning is a machine learning approach that enables an intelligent agent to learn optimal strategies through interactions with the environment. In a blockchain-based federated learning framework utilizing reinforcement learning, the reinforcement learning algorithm can dynamically adjust the timing of model aggregation, selection of data participants, and transaction costs. This achieves a balance between information timeliness and data bias, as well as intelligent control over transaction costs, ultimately optimizing the overall learning performance.

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CSX Corporation ("CSX" or "the Company") (NASDAQ: CSX) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. CSX is the subject of a Bloomberg article published on October 17, 2024, which states that the Company "received a subpoena from the US Securities and Exchange Commission focused on previously disclosed accounting errors and certain non-financial performance metrics." According to the article, "The subpoena asked the railroad company to produce documents about accounting mistakes CSX disclosed in its previous quarterly report, according to a regulatory filing on Thursday. The company received the subpoena this month and is cooperating with the probe, CSX said in the filing."

Closed transactions with MannKind Corporation validating the potential value of iSPERSE™ technology

Pursuing strategic alternatives to further leverage iSPERSE™ and optimize the potential of PUR3100

Completed PUR1900 wind down activities

Cash runway projected into Q4 2026

FRAMINGHAM, Mass., Nov. 8, 2024 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious central nervous system and pulmonary disease using its patented dry powder inhalation iSPERSE™ technology, today announced third quarter financial results for 2024 and provided a corporate update on its clinical assets.

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE: ELAN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

WORLDWIDE HEALTHCARE TRUST PLC

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 7 November 2024 was 381.03p (cum income).                                                                     

For and on behalf of the Board                      

Frostrow Capital LLP

Secretary                                                                  

08 November 2024

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE: PACS) for violations of the securities laws.

According to the Complaint, the Company made false and misleading statements to the market. PACS Group is the subject of a report issued by Hindenburg Research on November 4, 2024, titled: "PACS Group: How to Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers." The report alleges that, "PACS abused a COVID-era waiver, inappropriately accessing skilled care Medicare benefits for thousands of patients across its national portfolio of facilities." Hindenburg further alleges that "the scheme drove more than 100% of PACS' operating and net income from 2020 - 2023, enabling PACS to IPO in early 2024 with the illusion of legitimate growth and profitability."

THE BIOTECH GROWTH TRUST PLC

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 7 November 2024 was 1101.97p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

08 November 2024

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA Biologics" or "the Company") (NASDAQ: ADMA) for violations of the securities laws.

According to the Complaint, the Company made false and misleading statements to the market. ADMA Biologics admitted the abrupt resignation of its independent outside auditor, CohnReznick LLP., on October 9, 2024. The Company's shares lost more than 16.3% the next day based on this news.

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Evolv Technologies Holdings, Inc. ("Evolv" or "the Company") (NASDAQ: EVLV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

PACIFIC ASSETS TRUST PLC                                                                                                                

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Pacific Assets Trust plc at the close of business on 7 November 2024 was 429.68p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

08 November 2024

MENHADEN RESOURCE EFFICIENCY PLC

NET ASSET VALUE

The estimated un-audited net asset value per share for Menhaden Resource Efficiency PLC, calculated in accordance with the guidelines of the Association of Investment Companies, at the close of business on 7 November 2024 was 170.97p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary                                                  

08 November 2024

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Evolv To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $75,000 in Evolv between August 19, 2022 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolv Technologies Holdings, Inc. ("Evolv" or the "Company") (NASDAQ: EVLV) and reminds investors of the December 31, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

CAPITAL GEARING TRUST P.L.C.

(the "Company")

LEI:213800T2PJTPVF1UGW53

Date: 8 November 2024

Net Asset Value

The Company announces that, as at the close of business on 7 November 2024, the unaudited net asset values per ordinary share, valued on a 'bid price' basis, were:

Capital only: 4,794.64p

Including income: 4,837.21p

Frostrow Capital LLP

Company Secretary

Email: company.secretary@capitalgearingtrust.com

MIGO OPPORTUNITIES TRUST PLC

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for MIGO Opportunities Trust plc at the close of business on 7 November 2024 was 361.81p (ex-income) 362.93p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Company Secretary

08 November 2024

TEMPLE BAR INVESTMENT TRUST Plc

NET ASSET VALUE

It is announced that at the close of business on 7 November 2024 the unaudited net asset values (NAVs) per ordinary share of Temple Bar Investment Trust Plc managed by RWC Asset Management LLP are as follows.

For and on behalf of the Board

Frostrow Capital LLP

Secretary

8 November 2024

Legal Entity Identifier 213800O8EAP4SG5JD323

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elanco To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 in Elanco between November 7, 2023 and June 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) and reminds investors of the December 6, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.